Achieve Life Sciences, Inc. (ACHV) vs ArriVent BioPharma, Inc. (AVBP)

A side-by-side comparison of Achieve Life Sciences, Inc. and ArriVent BioPharma, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Achieve Life Sciences, Inc. logo
ACHV
Achieve Life Sciences, Inc.
$722M
$7.03HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
ArriVent BioPharma, Inc. logo
AVBP
ArriVent BioPharma, Inc.
$703M
$15.09HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — ACHV vs AVBP

growth of $100 · dividends reinvested · last 3y
ACHV +62.3% (+17.5%/yr)AVBP +42.3% (+12.5%/yr)ACHV compounded faster over this window
50100150Start $10020252026$162$142
ACHV AVBP

ACHV vs AVBP: by the numbers

  • •ACHV is the larger company ($722M vs $703M market cap).

Metrics side by side

Valuation

MetricACHVAVBP
P/B ratioN/A1.92

Profitability

MetricACHVAVBP
Gross margin0.00%0.00%
Operating margin0.00%0.00%
Net margin0.00%0.00%
ROEN/A-44.63%
ROICN/A-47.96%

Growth (annualized)

MetricACHVAVBP
Total return CAGR (5Y)-4.33%N/A

Go deeper

Full ACHV analysisFull AVBP analysisInteractive comparison tool

Dig into the metrics

Achieve Life Sciences ROEArriVent BioPharma ROEAchieve Life Sciences operating marginArriVent BioPharma operating marginAchieve Life Sciences revenue growthArriVent BioPharma revenue growthAchieve Life Sciences free cash flowArriVent BioPharma free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.